Evidence map›Paper›PMID 34250840›Full record

SynthesisInternational journal of immunopathology and pharmacology

Different dose of new generation proton pump inhibitors for the treatment of

Wenwen Gao, Xiang Zhang, Yanhui Yin, Shuwen Yu, Lu Wang

Open access · goldAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. The prevalence and treatment outcomes ofJGH open : an open access journal of gastroenterology and hepatology · 2023
    Article
  3. Helicobacter pylori infection.Nature reviews. Disease primers · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wenwen GaoDepartment of Pharmacy, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.ORCID https://orcid.org/0000-0002-6176-8668
Xiang ZhangDepartment of Pharmacy, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yanhui YinDepartment of Pharmacy, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Shuwen YuDepartment of Pharmacy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Lu WangDepartment of Pharmacy, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Jinan Central Hospital · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evidence on whether high-dose new generation proton pump inhibitors (PPIs) including rabeprazole and esomeprazole achieve a higher eradication rate of

Indexed as

Helicobacter pyloriAsian PeopleDose-Response Relationship, DrugDrug Resistance, MicrobialEsomeprazoleHelicobacter InfectionsHumansProton Pump InhibitorsRabeprazoleWhite PeopleEsomeprazoleProton Pump InhibitorsRabeprazoleClarithromycin resistancedifferent doseesomeprazoleethnic differenceHelicobacter pylorimeta-analysisnew generation proton pump inhibitorsrabeprazole

Identifiers

PMID34250840
PMCPMC8274125
OpenAlexW3179772354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.